Brain Protection Conferred by Long-Term Administration of 2-(2-Benzofuranyl)-2-Imidazoline Against Experimental Autoimmune Encephalomyelitis

Fast, Non-Competitive and Reversible Inhibition of NMDA-Activated Currents by 2-BFI Confers Neuroprotection

(2013) Zhao Han et al.   PLoS One

Neurovascular protection conferred by 2-BFI treatment during rat cerebral ischemia

(2012) Zhao Han et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

2-BFI ameliorates EAE-induced mouse spinal cord damage: Effective therapeutic time window and possible mechanisms

(2012) Fang Li et al.   BRAIN RESEARCH

2-BFI attenuates experimental autoimmune encephalomyelitis-induced spinal cord injury with enhanced B-CK, CaATPase, but reduced calpain activity

(2011) Pei Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

2-(-2-benzofuranyl)-2-imidazoline induces Bcl-2 expression and provides neuroprotection against transient cerebral ischemia in rats

(2010) Zhao Han et al.   BRAIN RESEARCH

IL-17 and Th17 Cells

(2009) Thomas Korn et al.   Annual Review of Immunology

Reversible inhibition of intracellular calcium influx through NMDA receptors by imidazoline I2 receptor antagonists

(2009) Susan X. Jiang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Idazoxan attenuates spinal cord injury by enhanced astrocytic activation and reduced microglial activation in rat experimental autoimmune encephalomyelitis

(2008) Xin-Shi Wang et al.   BRAIN RESEARCH

Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice

(2008) Joel N. H. Stern et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Th17 Cells and Autoimmune Encephalomyelitis (EAE/MS)

(2008) Toshimasa Aranami et al.   ALLERGOLOGY INTERNATIONAL